Javier A. Menendez1,Catalan Institute of Oncology, Girona (Catalonia, Spain)2Girona Biomedical Research Institute, Girona (Catalonia, Spain), Sílvia Cufí1,Catalan Institute of Oncology, Girona (Catalonia, Spain)2Girona Biomedical Research Institute, Girona (Catalonia, Spain), Cristina Oliveras-Ferraros1,Catalan Institute of Oncology, Girona (Catalonia, Spain)2Girona Biomedical Research Institute, Girona (Catalonia, Spain), Luciano Vellon3Fundación INBIOMED, Cell Reprogramming Unit, San Sebastián (Basque Country, Spain), Jorge Joven4Centre de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d'Investigaciò Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Catalonia, Spain), Alejandro Vazquez-Martin1,Catalan Institute of Oncology, Girona (Catalonia, Spain)2Girona Biomedical Research Institute, Girona (Catalonia, Spain)
- 1Catalan Institute of Oncology, Girona (Catalonia, Spain)
- 2Girona Biomedical Research Institute, Girona (Catalonia, Spain)
- 3Fundación INBIOMED, Cell Reprogramming Unit, San Sebastián (Basque Country, Spain)
- 4Centre de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d'Investigaciò Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Catalonia, Spain)